12.09.2024 15:46:40
|
CVS Health Says Hormonal Contraceptive Prescribing Now Available At CVS Pharmacies In Massachusetts
(RTTNews) - CVS Health (CVS) announced Thursday that CVS Pharmacy locations in Massachusetts are now offering hormonal contraceptive prescribing services. Patients interested in receiving a birth control prescription can be evaluated by a CVS pharmacist and, if clinically eligible, receive a prescription for birth control.
The new birth control prescribing service at CVS Pharmacy will help to close this gap and provide Massachusetts patients with convenient and affordable access to care when and where they need it.
Hormonal contraceptive prescribing was authorized as part of the Massachusetts 2024 State Budget, which was signed in August 2023 and was co-sponsored by State Senator Michael Moore and State Representatives Christine Barber and Lindsay Sabadosa.
Patients, 18 and older, interested in birth control can visit any Massachusetts CVS Pharmacy location and ask for a birth control consultation with a pharmacist. The consultation will cost $39, regardless of whether medication is prescribed, which can be covered by HSA or FSA funds.
All the nearly 400 CVS Pharmacy locations in Massachusetts are offering birth control prescribing. The service is also offered at CVS Pharmacy locations in California, Hawaii, Idaho, Michigan, Minnesota, Montana, Nebraska, South Dakota, Washington, and Wisconsin.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu CVS Health Corpmehr Nachrichten
28.01.25 |
Erste Schätzungen: CVS Health stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net) | |
24.01.25 |
S&P 500-Titel CVS Health-Aktie: So viel Verlust hätte eine CVS Health-Investition von vor 10 Jahren eingebracht (finanzen.at) | |
17.01.25 |
S&P 500-Titel CVS Health-Aktie: So viel Verlust hätte ein Investment in CVS Health von vor 5 Jahren bedeutet (finanzen.at) | |
13.01.25 |
Pluszeichen in New York: S&P 500 zum Handelsende fester (finanzen.at) | |
13.01.25 |
Schwache Performance in New York: S&P 500 zeigt sich schwächer (finanzen.at) | |
13.01.25 |
Börse New York in Rot: So steht der S&P 500 am Montagmittag (finanzen.at) | |
13.01.25 |
NYSE-Handel S&P 500 verbucht zum Start des Montagshandels Abschläge (finanzen.at) | |
10.01.25 |
Minuszeichen in New York: S&P 500 präsentiert sich schlussendlich schwächer (finanzen.at) |
Analysen zu CVS Health Corpmehr Analysen
Aktien in diesem Artikel
CVS Health Corp | 54,66 | 0,64% |